Blood Tests to Find Cancer | GVHD | Triple-Negative Breast Cancer, Cancer Information Highlights, June 10, 2020

Blood Tests to Find Cancer | GVHD | Triple-Negative Breast Cancer, Cancer Information Highlights, June 10, 2020

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Blood Test Might Find Early Cancers   A blood test combined with imaging tests found tumors in women with no history of cancer or symptoms, a recent study showed. Learn what may be next for this very early research. Targeted Drug Helps Some with Graft-Versus-Host Disease   People with acute graft-versus-host disease (GVHD) that does not respond to steroid therapy may be more likely to respond to the drug ruxolitinib (Jakafi) than other treatments. Read more about GVHD and the clinical trial that led to this finding. New Treatment Approved for Triple-Negative Breast Cancer   The Food and Drug Administration (FDA) has approved sacituzumab govitecan (Trodelvy) for the treatment of triple-negative breast cancer that has spread to other parts of the body. Under the approval, patients must have already had at least two types of treatment. New Approach for Treating People with Severe COVID-19 Early results from an NCI clinical trial suggest that a cancer drug that blocks a certain protein may help people with severe COVID-19 breathing problems. Learn more about how this drug works and where the findings from this clinical trial may lead. Important Treatment Advance for Liver Cancer   An immunotherapy and targeted therapy combo has been approved to treat liver cancer. Learn more about liver cancer, the studies that led to this approval, and ongoing treatment studies for this cancer. Less Toxic Treatment for Adults with Burkitt Lymphoma Adults with Burkitt lymphoma are often treated with very high doses of chemotherapy, which can be toxic to them. Learn about a study that looked at tailoring the dose of chemotherapy that adults were given to make treatment easier for them to bear. PDQ Updates Cancer Screening Overview We've updated this overview with information about bias caused by screening healthy people for cancer. People with early-stage cancer found by screening may live longer than people who don’t get screened not because of the cancer screening itself, but because of the benefits of a healthy lifestyle. FDA Approvals New Treatment for Liver Cancer We’ve updated our drug summaries for atezolizumab (Tecentriq) and bevacizumab (Avastin). FDA recently approved this drug combo for the treatment of certain patients with hepatocellular carcinoma (a type of liver cancer) that has spread to other parts of the body or cannot be removed by surgery.   Also of Interest Coronavirus and Cancer Many people with cancer have questions about coronavirus. This new web page presents information about coronavirus and COVID-19, including: what patients with cancer should know about the virus how the disease may affect their cancer care research studies for people with cancer and COVID-19 news about NCI’s response to COVID-19